Polymerization of fibrinogen Philadelphia and clot structure as characterized by turbidity and electron microscopy
. | . | . | Maximum rate, × 10-5 sec-1 . | . | Turbidity, optical density at 350 nm . | . | . | . | . | . | Fiber diameter, nm . | . | . | . | . | . | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Experimental condition . | Lag period, min . | . | . | . | Control . | . | . | Philadelphia . | . | . | Control . | . | . | Philadelphia . | . | . | |||||||||||
. | Control . | Phil . | Control . | Phil . | 2 min . | 10 min . | 30 min . | 2 min . | 10 min . | 30 min . | 2 min . | 10 min . | 30 min . | 2 min . | 10 min . | 30 min . | |||||||||||
0.20 M Ca++ | 1.1 ± 0.3* | 0.6 ± 0.2* | 140 ± 18* | 180 ± 23* | 0.10 ± 0.05* | 0.73 ± 0.08* | 0.90 ± 0.09* | 0.19 ± 0.07* | 0.64 ± 0.09* | 0.75 ± 0.08* | 56 ± 14† | 75 ± 27*† | 111 ± 21*‡ | 57 ± 15† | 62 ± 20*† | 91 ± 19*‡ | |||||||||||
0.20 M citrate | 0.8 ± 0.2 | 0.8 ± 0.2 | 25 ± 5* | 17 ± 4* | 0.02 ± 0.01 | 0.20 ± 0.06* | 0.24 ± 0.07* | 0.02 ± 0.01 | 0.11 ± 0.05* | 0.16 ± 0.06* | — | 41 ± 11†§ | — | — | 45 ± 11†§ | — | |||||||||||
0.4 M Ca++ | 0 | 0 | 5 ± 1* | 1 ± 0.5* | 0.015 ± 0.003§ | 0.035 ± 0.010* | — | 0.018 ± 0.004§ | 0.020 ± 0.009* | — | — | 54 ± 15*† | — | — | 48 ± 14*† | — | |||||||||||
0.05 M citrate | 0.6 ± 0.2* | 0.3 ± 0.2* | 140 ± 20 | 140 ± 17 | 0.13 ± 0.07* | 0.74 ± 0.10 | 0.98 ± 0.10 | 0.21 ± 0.08* | 0.72 ± 0.09 | 0.98 ± 0.11 | — | — | — | — | — | — |
. | . | . | Maximum rate, × 10-5 sec-1 . | . | Turbidity, optical density at 350 nm . | . | . | . | . | . | Fiber diameter, nm . | . | . | . | . | . | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Experimental condition . | Lag period, min . | . | . | . | Control . | . | . | Philadelphia . | . | . | Control . | . | . | Philadelphia . | . | . | |||||||||||
. | Control . | Phil . | Control . | Phil . | 2 min . | 10 min . | 30 min . | 2 min . | 10 min . | 30 min . | 2 min . | 10 min . | 30 min . | 2 min . | 10 min . | 30 min . | |||||||||||
0.20 M Ca++ | 1.1 ± 0.3* | 0.6 ± 0.2* | 140 ± 18* | 180 ± 23* | 0.10 ± 0.05* | 0.73 ± 0.08* | 0.90 ± 0.09* | 0.19 ± 0.07* | 0.64 ± 0.09* | 0.75 ± 0.08* | 56 ± 14† | 75 ± 27*† | 111 ± 21*‡ | 57 ± 15† | 62 ± 20*† | 91 ± 19*‡ | |||||||||||
0.20 M citrate | 0.8 ± 0.2 | 0.8 ± 0.2 | 25 ± 5* | 17 ± 4* | 0.02 ± 0.01 | 0.20 ± 0.06* | 0.24 ± 0.07* | 0.02 ± 0.01 | 0.11 ± 0.05* | 0.16 ± 0.06* | — | 41 ± 11†§ | — | — | 45 ± 11†§ | — | |||||||||||
0.4 M Ca++ | 0 | 0 | 5 ± 1* | 1 ± 0.5* | 0.015 ± 0.003§ | 0.035 ± 0.010* | — | 0.018 ± 0.004§ | 0.020 ± 0.009* | — | — | 54 ± 15*† | — | — | 48 ± 14*† | — | |||||||||||
0.05 M citrate | 0.6 ± 0.2* | 0.3 ± 0.2* | 140 ± 20 | 140 ± 17 | 0.13 ± 0.07* | 0.74 ± 0.10 | 0.98 ± 0.10 | 0.21 ± 0.08* | 0.72 ± 0.09 | 0.98 ± 0.11 | — | — | — | — | — | — |
For turbidity and fiber diameters, the numbers of observations were 10 and 500, respectively.
Phil indicates fibrinogen Philadelphia; —, not determined.
P < .0001 versus control.
P < .001 versus control.
Indicates fiber diameter measurements from transmission electron micrographs of negatively contrasted fibrin.
Indicates fiber diameter measurements from scanning electron micrographs of fibrin clots.